YU9003A - Farmaceutski sastav koji sadrži citalopram - Google Patents

Farmaceutski sastav koji sadrži citalopram

Info

Publication number
YU9003A
YU9003A YU9003A YUP9003A YU9003A YU 9003 A YU9003 A YU 9003A YU 9003 A YU9003 A YU 9003A YU P9003 A YUP9003 A YU P9003A YU 9003 A YU9003 A YU 9003A
Authority
YU
Yugoslavia
Prior art keywords
citalopram
pharmaceutical composition
composition containing
containing citalopram
mixture
Prior art date
Application number
YU9003A
Other languages
English (en)
Serbo-Croatian (sh)
Inventor
Ken Liljegren
Per Holm
Ole Nielsen
Sven Wagner
Original Assignee
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26068858&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU9003(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S
Publication of YU9003A publication Critical patent/YU9003A/sh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
YU9003A 2000-08-10 2001-07-30 Farmaceutski sastav koji sadrži citalopram YU9003A (sh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200001202 2000-08-10
DKPA200001614 2000-10-27

Publications (1)

Publication Number Publication Date
YU9003A true YU9003A (sh) 2006-05-25

Family

ID=26068858

Family Applications (1)

Application Number Title Priority Date Filing Date
YU9003A YU9003A (sh) 2000-08-10 2001-07-30 Farmaceutski sastav koji sadrži citalopram

Country Status (34)

Country Link
EP (1) EP1318805A2 (de)
JP (1) JP2003531153A (de)
KR (1) KR20030024833A (de)
CN (1) CN1446089A (de)
AR (1) AR030095A1 (de)
AT (1) AT5744U1 (de)
AU (2) AU2001100198B4 (de)
BE (1) BE1013559A6 (de)
BG (1) BG107578A (de)
BR (1) BR0113250A (de)
CA (1) CA2353693C (de)
CH (2) CH694242A5 (de)
CZ (1) CZ2003397A3 (de)
DE (2) DE10139115A1 (de)
EA (1) EA200300247A1 (de)
ES (1) ES2172481B2 (de)
FI (1) FI5176U1 (de)
FR (1) FR2812811B1 (de)
GB (1) GB2368014B (de)
GR (1) GR1004193B (de)
HR (1) HRP20030054A2 (de)
HU (1) HUP0103071A3 (de)
IE (1) IES20010693A2 (de)
IL (1) IL154050A0 (de)
IS (1) IS6021A (de)
IT (1) ITMI20011637A1 (de)
MX (1) MXPA03000837A (de)
NL (1) NL1018741C1 (de)
NO (1) NO20013891L (de)
NZ (1) NZ523785A (de)
PL (1) PL359824A1 (de)
SK (1) SK2842003A3 (de)
WO (1) WO2001080619A2 (de)
YU (1) YU9003A (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2353693C (en) * 2000-08-10 2003-07-22 H. Lundbeck A/S Pharmaceutical composition containing citalopram
AU2001100195B4 (en) * 2001-01-05 2001-12-20 H Lundbeck As Pharmaceutical composition containing citalopram.
GB0206708D0 (en) * 2002-03-21 2002-05-01 Cipla Ltd Pharmaceutical salts
US6812355B2 (en) 2002-10-22 2004-11-02 Sekhsaria Chemicals Limited Process for the manufacture of citalopram hydrobromide from 5-bromophthalide
CN100349885C (zh) * 2002-12-23 2007-11-21 H·隆德贝克有限公司 依他普仑氢溴酸盐及其制备方法
WO2004103361A2 (en) * 2003-05-20 2004-12-02 Ranbaxy Laboratories Limited A pharmaceutical dosage form of citalopram
HU227491B1 (en) * 2003-11-25 2011-07-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Tablet containing citalopram hydrogen bromide
WO2006038217A1 (en) * 2004-10-05 2006-04-13 Strides Acrolab Limited An improved drug delivery system of citalopram hydrobromide and process for producing the same
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
CN100353939C (zh) * 2006-01-05 2007-12-12 昆明积大制药有限公司 含西酞普兰和环糊精的抗抑郁口服药用组合物
GB2480191A (en) * 2007-02-02 2011-11-09 Ubiquisys Ltd Determining the location of a base station
CN106397249A (zh) * 2015-08-03 2017-02-15 深圳信立泰药业股份有限公司 一种高稳定性lcz696结晶粉末及其制备方法
EP4277661A1 (de) * 2021-01-18 2023-11-22 Anton Frenkel Pharmazeutische darreichungsform

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1358915A (en) * 1919-04-14 1920-11-16 Amici Domenico Aeroplane
GB1358915A (en) * 1971-09-13 1974-07-03 Merck & Co Inc Directly compressed tablet and composition therefor
GB1526331A (en) 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
US5296507A (en) * 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
EP0714663A3 (de) * 1994-11-28 1997-01-15 Lilly Co Eli Potenzierung von Wirkstoffresponz durch Serotonin 1A Rezeptor Antagonisten
GB9714841D0 (en) * 1997-07-14 1997-09-17 Smithkline Beecham Plc Treatment method
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
US6977306B2 (en) 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof
CA2353693C (en) * 2000-08-10 2003-07-22 H. Lundbeck A/S Pharmaceutical composition containing citalopram

Also Published As

Publication number Publication date
HU0103071D0 (en) 2001-10-28
DE20113195U1 (de) 2001-11-15
KR20030024833A (ko) 2003-03-26
WO2001080619A3 (en) 2002-02-21
EA200300247A1 (ru) 2003-06-26
IES20010693A2 (en) 2002-07-10
CZ2003397A3 (cs) 2003-06-18
AU2001100198A4 (en) 2001-08-16
SK2842003A3 (en) 2003-09-11
ITMI20011637A1 (it) 2003-01-27
BG107578A (bg) 2003-09-30
GB2368014B (en) 2004-06-23
AU2001279591A1 (en) 2001-11-07
BR0113250A (pt) 2003-06-24
MXPA03000837A (es) 2003-06-06
CA2353693C (en) 2003-07-22
FI5176U1 (fi) 2001-12-27
PL359824A1 (en) 2004-09-06
BE1013559A6 (fr) 2002-03-05
HUP0103071A2 (hu) 2002-05-29
NO20013891D0 (no) 2001-08-09
AT5744U1 (de) 2002-11-25
CN1446089A (zh) 2003-10-01
FR2812811A1 (fr) 2002-02-15
ITMI20011637A0 (it) 2001-07-27
GB2368014A (en) 2002-04-24
GB0118579D0 (en) 2001-09-19
IS6021A (is) 2001-10-20
CA2353693A1 (en) 2002-01-22
IL154050A0 (en) 2003-07-31
GR20010100377A (el) 2002-09-06
CH694242A5 (de) 2004-10-15
NZ523785A (en) 2004-09-24
GR1004193B (el) 2003-03-24
HUP0103071A3 (en) 2002-12-28
CH694241A5 (de) 2004-10-15
NL1018741C1 (nl) 2002-02-12
HRP20030054A2 (en) 2005-02-28
JP2003531153A (ja) 2003-10-21
ES2172481A1 (es) 2002-09-16
FR2812811B1 (fr) 2006-08-18
ES2172481B2 (es) 2004-08-01
DE10139115A1 (de) 2002-03-28
WO2001080619A2 (en) 2001-11-01
AR030095A1 (es) 2003-08-13
EP1318805A2 (de) 2003-06-18
NO20013891L (no) 2002-02-11
AU2001100198B4 (en) 2002-06-13

Similar Documents

Publication Publication Date Title
DE69620606T2 (de) Feste oral anzuwendende arzeneiform
ES2172481A1 (es) Composicion farmaceutica que contiene citalopram.
UA41346C2 (uk) Фармацевтична композиція, яка містить флуоксетин або його сіль, таблетка на її основі, спосіб виробництва таблетки, яка диспергується
RU2003116058A (ru) Композиции гидрокодона с контролируемым высвобождением
DK1117383T3 (da) Doseringsformer omfattende terapeutisk formulering
CA2326517A1 (en) New galenic preparations of meloxicam for oral administration
MX2007015480A (es) Formulaciones de dosificacion solida de medicamentos narcoticos que tienen adsorcion bucal mejorada.
HUP0301390A2 (hu) Valzartánt tartalmazó orális gyógyászati készítmény
AP2003002763A0 (en) Controlled release formulations for oral administration
RU2003100507A (ru) Фармацевтические композиции
MXPA03011317A (es) Comprimido masticable que comprende paracetamol.
SE8901003L (sv) Snabbloesliga preparat
CA2432177A1 (en) Drug for prevention and/or therapy of endometriosis
HUP0203148A2 (hu) Mirtazapint tartalmazó orálisan dezintegrálódó készítmény
TW200517127A (en) Novel composition
YU54503A (sh) Farmaceutski sastav koji sadrži citalopram
GEP20043377B (en) Pharmaceutical Complex
SI1530459T1 (sl) Oralni farmacevtski sestavek za mehke kapsule, ki vsebujejo vinorelbin in postopek obdelave
MXPA06000363A (es) Forma de dosificacion oral de mesilato de saquinavir.
MY131159A (en) New pharmaceutical compositions containing epinastine and pseudoephedrine
RU2002126216A (ru) Фармацевтическая композиция для лечения и профилактики фиброза и цирроза печени
RU96111879A (ru) Способ приготовления гомеопатических мягких лекарственных форм
PE20030546A1 (es) Una forma de unidad de dosis farmaceutica del tipo de capsulas rigidas que contiene clonixinato de lisina, un procedimiento para su preparacion y el uso de dicha unidad de dosis como analgesico y/o antiinflamatorio
PL355467A1 (en) Pharmaceutical composition for filling hard gelatine capsules, method of producing pharmaceutical composition for filling hard gelatine capsules and hard the hard gelatine capsules